X0306 4 2020-04-28 false 0001597553 Sage Therapeutics, Inc. SAGE 0001320559 Cook Anne Marie C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false SVP, GC & Secretary Stock Option (Right to Buy) 39.87 2020-04-28 4 A false 9450.00 0.00 A 2030-04-28 Common Stock 9450.00 9450.00 D The securities awarded on April 28, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. 25% of the shares of common stock underlying this stock option award will vest on April 28, 2021, and the remaining 75% of the shares of common stock underlying this stock option award will vest on April 28, 2022, subject, in each case, to the Reporting Person's continued employment with the Issuer on each of the applicable vesting dates. /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Anne Marie Cook 2020-04-30